Funding Opportunities in Cancer Research

 

research1  

For assistance with funding, contact: 
Paige Isom, Project Manager,
Funding and Awards
Phone: 314-454-8980
E-mail:  isomp@wudosis.wustl.edu

 

 

FUNDING OPPORTUNITY SEARCH TOOLS 

Siteman Cancer Center — Internal

Barnes-Jewish Foundation
  

Deadline Funding Opportunity Sponsor Amount Description
Dec. 9, 2014 NEW: Landon Foundation AACR INNOVATOR Award for Research in Tumor Microenvironment AACR $135,000 over two years The Landon Foundation-AACR INNOVATOR Award for Research in Tumor Microenvironment was established to recognize the outstanding achievement of a junior faculty-level scientist working in the tumor microenvironment field, and support his or her research that, if successful, will have potential to advance knowledge on the tumor microenvironment.
Dec. 9, 2014 NEW: Landon Foundation - AACR INNOVATOR Award for Cancer Prevention Research AACR $135,000 over two years The award was established to recognize the outstanding achievement of a junior faculty-level scientist working in the field of cancer prevention, and support his or her novel and innovative research that, if successful, will have the potential for high impact in the cancer prevention field.
LOI: Dec. 12, 2014 NEW: Lung Cancer Early Detection Award Lungevity Individuals - $200,000 over 2-3 years
Multidisciplinary teams - $600,000 over 2-3 years
2015 LUNGevity grant funds will be awarded to support translational research projects directed at new approaches to improve clinical methods for the detection and diagnosis of primary tumors. Applicants may apply as individuals or in teams.
LOI: Dec. 12, 2014 NEW: Lung Cancer Targeted Therapeutics Award Lungevity Individuals - $200,000 over 2-3 years
Multidisciplinary teams - $600,000 over 2.-3 years
2015 LUNGevity grant funds will be awarded to support translational research projects directed at targeted therapeutics, including immuno-oncology, that will make a difference in the clinical treatment and survival of patients. Applicants may apply as individuals or in teams.
LOI: Dec. 12, 2014 NEW: Career Development Award Lungevity $100,000 per year for three years To support future research leaders who will keep the field of lung cancer research vibrant with new ideas. Research projects are restricted to translational lung cancer research, and the applicant must demonstrate the translational relevance of the research proposed. The CDAs are mentored awards; a mentoring plan will be part of the required submission.NEW: Lung Cancer Targeted Therapeutics Award
Dec. 15, 2014 Young Investigator Grant Alex's Lemonade Stand Foundation $50,000 per year for two years Young Investigator Grants are designed as start-up funds for new scientists at the end of their fellowship training or early in their research career. Demonstration of outstanding mentorship and demonstration of a career plan that shows commitment to pediatric cancer investigation are critical components of a successful application.
INTERNAL COMPETITION: Jan. 5, 2015 NEW: Alvin J. Siteman Cancer Research Fund Washington University $300,000 per year This mechanism is intended to support innovative, translational research projects that have the promise of transforming cancer prevention, diagnosis, or treatment.
LOI: Feb. 1, 2015 NEW: Research Professor Grant American Cancer Society $80,000 per year for five years The American Cancer Society offers a limited number of grants to mid-career investigators who have made seminal contributions that have changed the direction of basic cancer research. Furthermore, it is expected that these investigators will continue to provide leadership in their research area.
Feb. 1, 2015 NEW: Pardee Foundation Cancer Research Grant Elsa U. Pardee Foundation Not limited Pardee Foundation grants are devoted to innovative approaches to conquering cancer, in particular they look to fund new scientist with cutting-edge ideas. Click to see previous awardees and amounts.
LOI: Feb. 15, 2015 NEW: Translational Research Program Leukemia & Lymphoma Society $200,000 per year for three years The Translational Research Program (TRP) puts you on the bench-to-bedside fast track when it comes to finding better treatment and cures for leukemia, lymphoma and myeloma. The Leukemia & Lymphoma Society (LLS) funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application. The goal of translational research is to reduce the time between laboratory findings and actual treatment.